Further, immunohistochemistry confirms that DE-EDCP reduced Ki-67 expression in breast cancer ex vivo, but there was no difference in the expression of Ki-67 in breast cancer from mice treated with cisplatin or vehicle. The gene discussed is MKI67; the disease is breast cancer.